Called Spravato, a brand name for esketamine, and developed by Johnson ... depending on the dose a patient needs, Johnson & Johnson said. In the first month of treatment, patients undergo ...
2mon
Medpage Today on MSNFDA Expands Approval of Esketamine for DepressionThe FDA approved esketamine (Spravato) nasal spray as monotherapy for adults with treatment-resistant depression who had an ...
The high-dose models, which are used by intravenous ... known risks of ketamine use (consider drug package insert data for esketamine nasal spray), as well as acknowledgment of the off-label ...
Lorazepam 1mg+, 1.5mg, 2mg, 3mg; ext-rel caps; +contains tartrazine. Swallow whole or open cap and sprinkle contents onto applesauce (1 tbsp). Administer the 1 st dose the day after the final dose ...
Elderly or hepatic impairment: initially 0.5mg/day. Switching from immediate-release alprazolam: give same total daily dose of immediate-release once daily, preferably in the AM. Increased risk of ...
7mon
SaltWire on MSN'Absolutely life-changing': New St. John’s clinic helping veterans overcome PTSD with esketamineChris McNee, a veteran from Brampton, Ontario, joined the infantry when he was just 17 years old. Today, he’s the veteran ambassador for NuVista Psychedelic Assisted Therapy . McNee had many ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results